Ken Kersemans

发表

Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts

C. Vanhove, O. De Wever, P. Pattyn, 2018, Radiation Oncology.

Gelatin- and starch-based hydrogels. Part A: Hydrogel development, characterization and coating.

Peter Dubruel, Kirsten Peters, Filip De Vos, 2016, Carbohydrate polymers.

18F-PSMA-11 Versus 68Ga-PSMA-11 Positron Emission Tomography/Computed Tomography for Staging and Biochemical Recurrence of Prostate Cancer: A Prospective Double-blind Randomised Cross-over Trial.

N. Lumen, K. Decaestecker, V. Fonteyne, 2022, European urology.

Establishment of a kinetic model for the intramolecular catalyzed hydrolysis of [18F]‐benzylfluoride containing amino acid analogues by linking experimental and DFT studies

P. Geerlings, J. Mertens, N. Sablon, 2012 .

Mechanistic approach of the difference in hydrolysis rate between the 2- and 4-isomers of no-carrier-added [18F]fluoromethyl-L-phenylalanine

P. Geerlings, F. Proft, J. Mertens, 2011 .

Radiosynthesis of 4-[18F]fluoromethyl-L-phenylalanine and [18F]FET via a same strategy and automated synthesis module

V. Caveliers, J. Mertens, Ken Kersemans, 2009 .

A critical quantum chemical and experimental study of the potentiality of direct labeling of the CN group with [(99m)Tc(CO)(3)](+) or [(186/188)Re(CO)(3)](+) in CN containing biomolecules.

P. Geerlings, J. Mertens, B. Safi, 2008, Nuclear medicine and biology.

Method for stabilizing non carrier added 2-[(18)F]fluoromethyl-l-phenylalanine, a new tumour tracer, during radiosynthesis and radiopharmaceutical formulation.

M. Bauwens, J. Mertens, Ken Kersemans, 2008, Nuclear medicine and biology.

Mechanistic approach of the difference in non‐enzymatic hydrolysis rate between the L and D enantiomers of no‐carrier added 2‐[18F]fluoromethyl‐phenylalanine

P. Geerlings, F. Proft, K. Kersemans, 2010 .

In vivo PET evaluation in tumour-bearing rats of 2-[18F]fluoromethyl-L-phenylalanine as a new potential tracer for molecular imaging of brain and extra-cranial tumours in humans with PET

A. Bossuyt, T. Lahoutte, M. Bauwens, 2007 .

In vivo characterization of 123/125I-2-iodo-L-phenylalanine in an R1M rhabdomyosarcoma athymic mouse model as a potential tumor tracer for SPECT.

Veerle Kersemans, Bart Cornelissen, Erik Achten, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma

C. Vanhove, S. van Calenbergh, K. Deblaere, 2019, Scientific Reports.

Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model

C. Vanhove, K. Deblaere, I. Goethals, 2019, Radiation Oncology.

Cell penetrating peptides for in vivo molecular imaging applications.

B. Cornelissen, V. Kersemans, Ken Kersemans, 2008, Current pharmaceutical design.

Biomimetic strategy towards gelatin coatings on PET. Effect of protocol on coating stability and cell-interactive properties.

S. Van Vlierberghe, P. Dubruel, C. Kirkpatrick, 2019, Journal of materials chemistry. B.

Involvement of the AT1 receptor subtype in the effects of angiotensin IV and LVV‐haemorphin 7 on hippocampal neurotransmitter levels and spatial working memory

Y. Michotte, G. Vauquelin, V. Caveliers, 2010, Journal of neurochemistry.

D- and L-[123I]-2-I-phenylalanine show a long tumour retention compared with D- and L-[123I]-2-I-tyrosine in R1M rhabdomyosarcoma tumour-bearing Wag/Rij rats.

A. Bossuyt, V. Caveliers, T. Lahoutte, 2007, Contrast media & molecular imaging.

Impact of 18F-PSMA-11 PET/CT on Management of Biochemical Recurrence and High-Risk Prostate Cancer Staging

N. Lumen, V. Fonteyne, L. Delrue, 2022, Molecular Imaging and Biology.

Hypoxia imaging with 18F-FAZA PET/CT predicts radiotherapy response in esophageal adenocarcinoma xenografts

C. Vanhove, O. De Wever, P. Pattyn, 2018, Radiation oncology.

Synthesis, in vitro and in vivo evaluation of 3β-[18F]fluorocholic acid for the detection of drug-induced cholestasis in mice

C. Vanhove, H. Van Vlierberghe, F. de Vos, 2017, PloS one.

Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.

B. Cornelissen, G. Slegers, V. Kersemans, 2006, Cancer biotherapy & radiopharmaceuticals.

Radiation Dosimetry and Biodistribution of 18F-PSMA-11 for PET Imaging of Prostate Cancer

E. Achten, N. Lumen, K. Decaestecker, 2019, The Journal of Nuclear Medicine.

In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.

Veerle Kersemans, Bart Cornelissen, Klaus Bacher, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Technical feasibility of [18F]FET and [18F]FAZA PET guided radiotherapy in a F98 glioblastoma rat model

C. Vanhove, K. Deblaere, I. Goethals, 2019, Radiation oncology.

Preliminary in vivo evaluation of [131I]-2-iodo-D-phenylalanine as a potential radionuclide therapeutic agent in R1M-fluc rhabdomyosarcoma tumor-bearing NuNu mice using bioluminescent imaging.

M. Vinken, A. Bossuyt, T. Lahoutte, 2010, Cancer biotherapy & radiopharmaceuticals.

10 PET for Therapy Response Assessment in Glioblastoma

C. Vanhove, K. Deblaere, M. Acou, 2017 .

Intra-individual comparison of the human biodistribution and dosimetry of the D and L isomers of 2-[123I]iodo-phenylalanine

A. Bossuyt, V. Caveliers, T. Lahoutte, 2007, Nuclear medicine communications.

Comparison of the uptake of [123/125I]-2-iodo-D-tyrosine and [123/125I]-2-iodo-L-tyrosine in R1M rhabdomyosarcoma cells in vitro and in R1M tumor-bearing Wag/Rij rats in vivo.

A. Bossuyt, C. Gallez, T. Lahoutte, 2006, Nuclear medicine and biology.

123/125I-labelled 2-iodo-L-phenylalanine and 2-iodo-D-phenylalanine: comparative uptake in various tumour types and biodistribution in mice

B. Cornelissen, G. Slegers, R. Dierckx, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Comparative biodistribution study of the new tumor tracer [123I]-2-iodo-L-phenylalanine with [123I]-2-iodo-L-tyrosine.

Veerle Kersemans, Bart Cornelissen, Guido Slegers, 2006, Nuclear medicine and biology.

Angiotensin AT4 receptor ligand interaction with cystinyl aminopeptidase and aminopeptidase N: [125I]Angiotensin IV only binds to the cystinyl aminopeptidase apo-enzyme.

Minh Tam Le, Patrick Vanderheyden, Yvette Michotte, 2006, European journal of pharmacology.

Preclinical comparative study of [18F]AlF-PSMA-11 and [18F]PSMA-1007 in varying PSMA expressing tumors

A. Vral, C. Vanhove, B. Descamps, 2022, Scientific Reports.

Radiolabeled gelatin type B analogues can be used for non-invasive visualisation and quantification of protein coatings on 3D porous implants

P. Dubruel, C. Vanhove, T. Desmet, 2012, Journal of Materials Science: Materials in Medicine.

Radiochemistry devoted to the production of monoamine oxidase (MAO-A and MAO-B) ligands for brain imaging with positron emission tomography.

F. de Vos, K. Kersemans, N. Van Laeken, 2013, Journal of labelled compounds & radiopharmaceuticals.

Bio-inspired surface modification of PET for cardiovascular applications: Case study of gelatin.

S. Van Vlierberghe, P. Dubruel, D. Schaubroeck, 2015, Colloids and surfaces. B, Biointerfaces.

Synthesis, in vitro and in vivo small-animal SPECT evaluation of novel technetium labeled bile acid analogues to study (altered) hepatic transporter function.

C. Vanhove, S. van Calenbergh, M. Huisman, 2016, Nuclear medicine and biology.

First step toward near-infrared continuous glucose monitoring: in vivo evaluation of antibody coupled biomaterials

Peter Dubruel, Filip De Vos, Maria Cornelissen, 2015, Experimental biology and medicine.

Impact of the molar activity and PSMA expression level on [18F]AlF-PSMA-11 uptake in prostate cancer

A. Vral, C. Vanhove, B. Descamps, 2021, Scientific Reports.

New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma

C. Vanhove, S. van Calenbergh, K. Deblaere, 2019, Scientific Reports.

Intra-individual dynamic comparison of 18F-PSMA-11 and 68Ga-PSMA-11 in LNCaP xenograft bearing mice

A. Vral, C. Vanhove, B. Descamps, 2020, Scientific Reports.

Optimization of PET protocol and interrater reliability of 18F-PSMA-11 imaging of prostate cancer

E. Achten, P. Ost, K. De Man, 2020, EJNMMI Research.

Evaluating Hepatobiliary Transport with 18F-Labeled Bile Acids: The Effect of Radiolabel Position and Bile Acid Structure on Radiosynthesis and In Vitro and In Vivo Performance

C. Vanhove, F. de Vos, Sara Neyt, 2018, Contrast media & molecular imaging.

Automated radiosynthesis of Al[18F]PSMA-11 for large scale routine use.

B. Brans, L. Moerman, K. De Man, 2018, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Improved HPLC purification strategy for [11C]raclopride and [11C]DASB leading to high radiochemical yields and more practical high quality radiopharmaceutical formulations.

I. Goethals, F. de Vos, K. Kersemans, 2013, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.